Greykasell Wealth Strategies’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Greykasell Wealth Strategies's AMGN Position: Q1 2026 in Review
Greykasell Wealth Strategies reduced its Amgen (AMGN) stake by 0.13% in Q1 2026, selling an estimated $1.43K and leaving 3,142 shares worth $1.11M. The position accounts for 0.45% of the portfolio, ranked #52.
Greykasell Wealth Strategies first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Greykasell Wealth Strategies held 3,142 shares of Amgen worth $1.11M as of Q1 2026.
- Greykasell Wealth Strategies sold 4 Amgen shares in Q1 2026, an estimated $1.43K.
- Amgen made up 0.45% of Greykasell Wealth Strategies's portfolio in Q1 2026, its #52 holding.
- Greykasell Wealth Strategies first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Greykasell Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.